Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE(TM)) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

Stock Information for Veru Inc.

Loading

Please wait while we load your information from QuoteMedia.